TScan Therapeutics Inc. Common Stock (TCRX)

Stock · NASDAQ · Health Care

$0.754as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Resistance level

$1.02

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Chosen by industry and closest market cap.

TCRX
TScan Therapeutics Inc. Common Stock
$0.754
▲ 0.53%
Market cap $47.27MP/E —
EXOZ
eXoZymes Inc. Common Stock
$7.17
▼ 0.10%
Market cap $47.57MP/E —
$4.35$18.4
TIL
Instil Bio Inc. Common Stock
$7.58
▼ 3.56%
Market cap $48.97MP/E —
$5.67$33.83
TVGN
Tevogen Inc. Common Stock
$6.89
▲ 2.07%
Market cap $45.04MP/E —
$3.64$49.5
INKT
MiNK Therapeutics Inc. Common Stock
$11.43
▼ 2.16%
Market cap $53.26MP/E —
$8.48$16.98
SCLX
Scilex Holding Company Common Stock
$5.42
▼ 2.69%
Market cap $55.70MP/E —
$4.2$34.27
DYAI
Dyadic International Inc. Common Stock
$0.6207
▼ 3.02%
Market cap $38.63MP/E —
$0.6197$1.6

Symbol	Market cap	P/E ratio	Price	1D	52-week range
TCRX TScan Therapeutics Inc. Common Stock	$47.27M	—	$0.754	▲ 0.53%
EXOZ eXoZymes Inc. Common Stock	$47.57M	—	$7.17	▼ 0.10%	$4.35$18.4
TIL Instil Bio Inc. Common Stock	$48.97M	—	$7.58	▼ 3.56%	$5.67$33.83
TVGN Tevogen Inc. Common Stock	$45.04M	—	$6.89	▲ 2.07%	$3.64$49.5
INKT MiNK Therapeutics Inc. Common Stock	$53.26M	—	$11.43	▼ 2.16%	$8.48$16.98
SCLX Scilex Holding Company Common Stock	$55.70M	—	$5.42	▼ 2.69%	$4.2$34.27
DYAI Dyadic International Inc. Common Stock	$38.63M	—	$0.6207	▼ 3.02%	$0.6197$1.6

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.